Ann: Bod to commence importing medicinal cannabis oil, page-3

With BDAs medical cannabis import license I believe management are absolutely on the right track to build a sustainable and profitable company.

I would suggest BDA to further pursue other unique MC strains from other partnerships in addition to Linnea. Then to test and formulate new MC products for distribution and sales.

Forget the cultivation pathway as it has significant regulatory burden and significant risks involved with significant dilution to our register.

This update is the pathway BDA needs to continue to focus on to ultimately generate sales.